re: enters human insulin market in pakistan From the report
The Commercialisation agreement between SciGen and PharmEvo is expected to generate in the order of over US$3 million dollars in revenue for SciGen over the three years following registration.
The agreement contains minimum order provisions. It is anticipated that
registration of SciGen's insulin in Pakistan will take about 9 months. SciGen's expert Regulatory Affairs team will work with PharmEvo and the Pakistani Authorities to move registration forward as quickly as possible.
Nice report which in time will mean extra income to Siegen in time ,but I am thinking it will pull back after a brief run up
- Forums
- ASX - General
- SIE
- re: enters human insulin market in pakistan
re: enters human insulin market in pakistan , page-2
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SIE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online